Eric C Lee MD
Lupus & Related, Rheumatoid Arthritis & Related, Vasculitis
Founding Director, Inland Rheumatology Clinical Trials
Join to View Full Profile
1238 E Arrow HwyUpland, CA 91786
Phone+1 909-982-0099
Fax+1 909-931-0402
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eric Lee is a rheumatologist based in Upland. He completed his residency and fellowship in Rheumatology at the University of California, Irvine, after graduating from Weill Cornell Medicine in 1997. Dr. Lee has experience in rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, Sjogren's syndrome, scleroderma, vasculitis, and ankylosing spondylitis. He has published several articles in prestigious journals, including Nature Medicine and Annals of the Rheumatic Diseases. Dr. Lee has been involved in multiple clinical trials related to rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, Sjogren's, and ankylosing spondylitis. He has received CMS Meaningful Use Stage 1 and 2 certifications.
Education & Training
University of California (Irvine)Fellowship, Rheumatology, 2000 - 2002- University of California (Irvine)Residency, Internal Medicine, 1997 - 2000
Weill Cornell MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1999 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Patient Chart Manager, Prime Clinical Systems, Inc., 2012, 2017
- CMS Meaningful Use Stage 1 Certification Patient Chart Manager, Prime Clinical Systems, Inc., 2012, 2017
- CMS Meaningful Use Stage 1 Certification Patient Chart Manager EHR, Prime Clinical Systems, 2011
Clinical Trials
- An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
- Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis Start of enrollment: 2015 Feb 21
Publications & Presentations
PubMed
- 2 citationsVagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial.John R P Tesser, Angela R Crowley, Emily Jane Box, Joshua P June, Pendleton Brewster Wickersham
Nature Medicine. 2026-01-01 - Plain language summary of the VOLTAIRE-RA in patients with moderate-to-severe rheumatoid arthritis.Stanley B Cohen, Eric C Lee
Immunotherapy. 2022-10-01 - 19 citationsLong-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheum...Stanley Cohen, Niklas Czeloth, Eric Lee, Piotr Adrian Klimiuk, Nuala Peter
Expert Opinion on Biological Therapy. 2019-08-06
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
